Biomaterial Database

[Heart transplantation. Experience at Stanford University: 221 cases]. 1982

M G Perlroth, and P E Oyer

UI	MeSH Term	Description	Entries
D007166	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.	Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009369	Neoplasms	New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011183	Postoperative Complications	Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.	Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011788	Quality of Life	A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease.	HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D002140	California	State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.
D005260	Female		Females
D006648	Histocompatibility	The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts.	HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M G Perlroth, and P E Oyer

[Heart transplantation at Stanford University].

April 1981, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,

M G Perlroth, and P E Oyer

Results of human heart transplantation at Stanford University.

March 1971, Transplantation proceedings,

M G Perlroth, and P E Oyer

Heart transplantation--Stanford experience.

January 1987, Clinical transplants,

M G Perlroth, and P E Oyer

Twenty-year survivors of heart transplantation at Stanford University.

September 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,

M G Perlroth, and P E Oyer

Review of four years experience with clinical heart transplantation at Stanford University Medical Center.

December 1972, Transplantation proceedings,

M G Perlroth, and P E Oyer

[Lung transplantation at Stanford University Hospital].

June 2005, Ugeskrift for laeger,

M G Perlroth, and P E Oyer

Liver transplantation at Stanford University Medical Center.

January 1998, Clinical transplants,

M G Perlroth, and P E Oyer

Heart and heart-lung transplantation: the Stanford experience.

January 1989, Clinical transplants,